UNDERWRITING AGREEMENT between ACURX PHARMACEUTICALS, INC. and ALEXANDER CAPITAL, L.P., as Representative of the Several UnderwritersUnderwriting Agreement • May 27th, 2021 • Acurx Pharmaceuticals, LLC • Pharmaceutical preparations • New York
ACURX PHARMACEUTICALS, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • May 27th, 2021 • Acurx Pharmaceuticals, LLC • Pharmaceutical preparations • Delaware
This Indemnification Agreement (this “Agreement”) is effective as of ______, 20__ by and between Acurx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and _________ (“Indemnitee”).
THE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL,...Purchase Warrant Agreement • May 27th, 2021 • Acurx Pharmaceuticals, LLC • Pharmaceutical preparations • New York
THIS PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO ___ [DATE THAT IS 180 DAYS FROM THE EFFECTIVE DATE OF THE OFFERING] VOID AFTER 5:00 P.M., EASTERN TIME, ____, 202__ [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING].
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 27th, 2021 • Acurx Pharmaceuticals, LLC • Pharmaceutical preparations • New York
This EMPLOYMENT AGREEMENT (the “Agreement”) is dated as of May 25, 2021 but only effective for all purposes as of the Effective Date (as defined below) by and between Acurx Pharmaceuticals, LLC, a Delaware limited liability company with principal executive offices located at 259 Liberty Avenue, Staten Island, NY 10305 (to be converted into a Delaware corporation and thereafter known as Acurx Pharmaceuticals, Inc., the “Company”), and Robert J. DeLuccia (the “Executive”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 27th, 2021 • Acurx Pharmaceuticals, LLC • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of _____, 20__, is made by and among Acurx Pharmaceuticals, Inc., a corporation organized under the laws of Delaware (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
ASSET PURCHASE AGREEMENT between ACURX PHARMACEUTICALS, LLC and GLSYNTHESIS INC., Dated February 5, 2018Asset Purchase Agreement • May 27th, 2021 • Acurx Pharmaceuticals, LLC • Pharmaceutical preparations • Delaware
Certain identified information has been omitted from this exhibit because it is not material and would likely cause competitive harm to the registrant if publicly disclosed. [***] indicates that information has been omitted.
